« Back
Home /
Dizocilpine (maleate)

Dizocilpine (maleate)

Item no.	HY-15084-50mg
Manufacturer	MedChem Express
CASRN	77086-22-7
Amount	50 mg
Quantity options	10 mM/1 mL 10 mg 50 mg 5 mg
Category	Food Safety Allergenes Neuroscience Molecular Targets for Neuroscience Targets for Rodent Neurosciences Neural Signaling Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.99
Citations	[1]Wong EH, et al. The anticonvulsant MK-801 is a potent N-Me-D-Asp antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8.\|[2]Vardhan Reddy KH, et al. Convergent Strategy to Dizocilpine MK-801 and Derivatives. J Org Chem. 2018 Apr 6;83(7):4264-4269.\|[3]Huettner JE, et al. Block of N-Me-D-Asp-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1307-11.\|[4]Thomas DM, et al. MK-801 and dextromethorphan block microglial activation and protect against neurotoxicity. Brain Res. 2005 Jul 19;1050(1-2):190-8.\|[5]Brown TE, et al. The NMDA antagonist MK-801 disrupts reconsolidation of a cocaine-associated memory for conditioned place preference but not for self-administration in rats. Learn Mem. 2008 Dec 2;15(12):857-65.\|[6]Jiang L, et al. Decrease of growth and differentiation factor 10 contributes to neuropathic pain through N-Me-D-Asp receptor activation. Neuroreport. 2017 May 24;28(8):444-450.\|[7]Iijima Y, et al. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist sensitization: evaluation by ambulation in mice. Nihon Shinkei Seishin Yakurigaku Zasshi. 1996 Feb;16(1):11-8. Cell. 2023 Nov 22;186(24):5347-5362.e24.\|Eur J Neurosci. 2024 Jul 23.\|Eur J Pharmacol. 2019 Aug 15;857:172427. \|Evid Based Complement Alternat Med. 2020 Mar 10;2020:3524641.\|Front Cell Dev Biol. 2020 Feb 4;8:24. \|Front Cell Neurosci. 2019 Jun 25;13:276.\|Front Neurosci. 2019 Nov 19;13:1225.\|Life Sci. 2022 Feb 17;295:120419.\|Mol Psychiatry. 2022 Jun 17.\|Neuropharmacology. 2024 Dec 24:110284.\|Neuroreport. 2017 May 24;28(8):444-450. \|Psychoneuroendocrinology. 2024 Oct:168:107138.\|Psychopharmacology (Berl). 2024 Nov 18.\|Res Sq. 2024 Jul 15.\|Sci Bull. 2024 Dec 27:S2095-9273(24)00949-6.\|Basic Clin Neurosci. 2021 Jul.\|Bioorg Med Chem. 2022 Feb 18;59:116675.\|Br J Pharmacol. 2020 Oct;177(20):4720-4733.\|Brain Res. 2023 May 17;1812:148409.\|Cell Biosci. 2023 Mar 16;13(1):57.\|Eur J Pharmacol. 2022 Oct 25;175343.\|Front Biosci (Landmark Ed). 2023 Jul 19, 28(7), 140.\|Int J Mol Sci. 2022 Dec 18;23(24):16150.\|J Cell Mol Med. 2020 Aug;24(16):9287-9299.\|J Med Chem. 2023 May 2.\|J Orthop Surg Res. 2025 Jan 23;20(1):83.\|J Physiol. 2023 Jul 8.\|Mol Neurobiol. 2023 Dec 8.\|Molecules. 2023 Mar 2.\|Nat Neurosci. 2021 Dec 9.\|Neuropharmacology. 2025 Jan 20:110318.\|Neurosci Lett. 2023 Sep 4;137471.\|RSC Adv. 2022 Oct 3;12(43):28098-28103.
Smiles	C[C@]12C3=CC=CC=C3C[C@@H](N2)C4=CC=CC=C14.O=C(O)/C=C\C(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	(+)-MK 801 Maleate
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Neuroscience-Neurodegeneration
Manufacturer - Targets	iGluR
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	337.37
Product Description	Dizocilpine maleate (MK-801 maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.
Manufacturer - Research Area	Neurological Disease
Solubility	DMSO: 133.33 mg/mL (ultrasonic)\|Ethanol: 25 mg/mL (ultrasonic)\|H2O: 7.69 mg/mL (ultrasonic)
Manufacturer - Pathway	Membrane Transporter/Ion Channel; Neuronal Signaling
Isoform	NMDA Receptor
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-15084-50mg-safety-datasheet.pdf